Congress Wealth Management LLC DE Sells 98 Shares of Teleflex Incorporated (NYSE:TFX)

Congress Wealth Management LLC DE decreased its stake in shares of Teleflex Incorporated (NYSE:TFX) by 6.6% during the 4th quarter, Holdings Channel reports. The institutional investor owned 1,390 shares of the medical technology company’s stock after selling 98 shares during the period. Congress Wealth Management LLC DE’s holdings in Teleflex were worth $247,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in TFX. Cerity Partners LLC lifted its position in shares of Teleflex by 49.3% during the third quarter. Cerity Partners LLC now owns 13,374 shares of the medical technology company’s stock worth $3,308,000 after purchasing an additional 4,415 shares in the last quarter. FMR LLC raised its position in Teleflex by 70.1% in the 3rd quarter. FMR LLC now owns 269,490 shares of the medical technology company’s stock worth $66,650,000 after purchasing an additional 111,086 shares during the last quarter. BNP Paribas Financial Markets lifted its holdings in Teleflex by 14.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 64,498 shares of the medical technology company’s stock worth $15,952,000 after buying an additional 7,907 shares in the last quarter. Townsquare Capital LLC acquired a new stake in shares of Teleflex in the 3rd quarter valued at $200,000. Finally, Glenmede Trust Co. NA increased its stake in shares of Teleflex by 5.9% in the 3rd quarter. Glenmede Trust Co. NA now owns 4,481 shares of the medical technology company’s stock valued at $1,108,000 after buying an additional 249 shares during the period. Institutional investors own 95.62% of the company’s stock.

Teleflex Stock Performance

Shares of Teleflex stock opened at $137.76 on Friday. The stock’s fifty day simple moving average is $159.20 and its 200 day simple moving average is $190.36. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $6.39 billion, a PE ratio of 27.39, a PEG ratio of 1.73 and a beta of 1.21. Teleflex Incorporated has a 12 month low of $128.55 and a 12 month high of $249.91.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. On average, research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.99%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex’s dividend payout ratio (DPR) is presently 95.77%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on TFX. Bank of America cut Teleflex from a “neutral” rating to an “underperform” rating and decreased their price target for the company from $235.00 to $140.00 in a report on Tuesday, March 4th. Piper Sandler reiterated a “neutral” rating and set a $140.00 price target (down previously from $255.00) on shares of Teleflex in a research report on Friday, February 28th. StockNews.com lowered shares of Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Citizens Jmp lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Wednesday, March 12th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $182.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.